Published in

Elsevier, Journal of Geriatric Oncology, 1(1), p. 20-26, 2010

DOI: 10.1016/j.jgo.2010.04.002

Elsevier, Critical Reviews in Oncology/Hematology, 2(75), p. 165-172, 2010

DOI: 10.1016/j.critrevonc.2010.06.012

Links

Tools

Export citation

Search in Google Scholar

Immunosenescence and cancer

Journal article published in 2010 by Graham Pawelec ORCID, Evelyna Derhovanessian, Anis Larbi
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Age is a major risk factor for many cancers. Although this is usually viewed in the context of the cell biology, we argue here that age-associated changes to immunity may also contribute to the age-associated increasing incidence of most cancers. This is because cancers are immunogenic (at least initially), and the immune system can and does protect against tumourigenesis. However, immune competence tends to decrease with age, a phenomenon loosely termed "immunosenescence", implying that decreased immunosurveillance against cancer could also contribute to increased disease in the elderly. This review weighs some of the evidence for and against this possibility.